Clinical Trial Update: A Long-Term Follow-Up Study of Subjects Completing the AU-011-301(CoMpass) for Early Choroidal Melanoma

View source ↗

Summary

Long-term follow-up results are reported for participants who completed the AU-011-301 (CoMpass) trial in early choroidal melanoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Choroidal Melanoma

Drugs mentioned

• AU-011 (Belzupacap Sarotalocan)

Snippet

Sponsor: Aura Biosciences | Conditions: Choroidal Melanoma, Indeterminate Lesions | Status: NOT_YET_RECRUITING